Back to search

Article

The role of endogenous inhibitors of nitric oxide on glucose homeostasis

2015-01-01

Abstract excerpt

Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide synthases. ADMA is metabolised by dimethylarginine dimethylaminohydrolase (DDAH) of which there are two isoforms with the same catalytic activity but different tissue expression patterns. Clinically ADMA is relevant as increased levels are seen in multiple pathologies, most notably cardiovascular disease and renal disease. Recent studies...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4125b498-7eea-5c5d-9915-671daccd1eb7
DOI
10.25560/24777
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The role of endogenous inhibitors of nitric oxide on glucose homeostasisDOI 10.25560/24777
Select a neighboring publication to make it the new centre.